Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating valbenazine for dyskinesia associated with cerebral palsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Dyskinesia

Drugs mentioned

• Valbenazine (valbenazine)

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Dyskinesia, Cerebral Palsy | Phase 3 | Status: COMPLETED